COVID 19 pandemic and cancer treatment: experience at a tertiary care centre
Keywords:Chemotherapy, COVID 19, Day care, Pandemic
Background: In these era COVID Pandemic patients are missing their chemotherapy due to multiple reasons. This study was undertaken to quantify the exact number of patients who had missed their appointment for chemotherapy.
Methods: All patients who had appointments for chemotherapy from 20th Mar to 20th Apr were included in the study. Details of malignancies, chemotherapy, duration of delay in patients coming for chemotherapy to be recorded.
Results: The total number appointments given for chemotherapy for various malignancies were 301 patients for various malignancies for the duration 20th March to 20th April. The total number of appointments given were 301. Out of the total of 301 patients who had appointment for chemotherapy during this period 131 patients could be given chemotherapy and 170 could not be given chemotherapy. The average delay was of 9 days. The data was distributed into four weeks from 20th March to 20th April. Just before the country wide lock down in first week 20th, 70 patients receiving chemotherapy which drastically reduced in later weeks. Both the cases who could come for chemotherapy and those who could not have been kept under follow up, up to 6 months to reassess their response.
Conclusions: This article has been written to highlight the number of patients who could not receive chemotherapy due to ongoing Pandemic with an intention to follow them up for 6 months. Since this pandemic is here to stay it is very important that formulate the working principle for administering chemotherapy.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020:1054-62.
Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335-7.
Chen Z, King W, Pearcey R, Kerba M, Mackillop WJ. The relationship between waiting time for radiotherapy and clinical outcomes: a systematic review of the literature. Radiother Oncol. 2008;87(1):3-16.
Raphael MJ, Biagi JJ, Kong W, Mates M, Booth CM, Mackillop WJ. The relationship between time to initiation of adjuvant chemotherapy and survival in breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treatment. 2016 Nov 1;160(1):17-28.
UNESCO. The precautionary principle. UNESCO World Commission on the Ethics of Scientific Knowledge and Technology (COMEST). 2005 May.
Ueda M, Martins R, Hendrie PC, McDonnell T, Crews JR, Wong TL, et al. Managing cancer care during the COVID-19 pandemic: agility and collaboration toward a common goal. J Nat Comprehen Cancer Net. 2020 Mar 20;1(aop):1-4.
ASCO COVID 19 Patients care information. Available at: https://www.asco.org/asco-coronavirus-information/care-individuals-cancer-during-covid-19. Accessed on 09/04/2020
Emanuel EJ, Persad G, Upshur R, Thome B, Parker M, Glickman A, et al. Fair allocation of scarce medical resources in the time of Covid-19. N Engl J Med. 2020;2020.
Curtis JR, Kross EK, Stapleton RD. The Importance of Addressing Advance Care Planning and Decisions About Do-Not-Resuscitate Orders During Novel Coronavirus 2019 (COVID-19). JAMA 2020.